Baker Brothers Advisors - ISIS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of ISIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$2,310,000
-29.7%
57,1400.0%0.02%
-27.6%
Q2 2015$3,288,000
-9.6%
57,1400.0%0.03%
-3.3%
Q1 2015$3,638,000
-38.8%
57,140
-40.7%
0.03%
-50.8%
Q4 2014$5,946,000
+59.0%
96,3030.0%0.06%
+29.8%
Q3 2014$3,739,000
+12.7%
96,3030.0%0.05%
+14.6%
Q2 2014$3,318,000
-20.3%
96,3030.0%0.04%
-22.6%
Q1 2014$4,161,000
-57.7%
96,303
-61.0%
0.05%
-61.9%
Q4 2013$9,842,000
+6.1%
247,0360.0%0.14%
+5.3%
Q3 2013$9,274,000
+39.7%
247,0360.0%0.13%
+0.8%
Q2 2013$6,638,000247,0360.13%
Other shareholders
ISIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BB BIOTECH AG 5,976,526$368,991,00011.95%
HWG Holdings LP 155,584$9,606,0006.84%
DOWLING & YAHNKE LLC 676,313$41,756,0005.20%
Ghost Tree Capital, LLC 150,000$9,261,0004.44%
WILLIAM HARRIS INVESTORS INC 276,870$17,094,0004.41%
GRAYBILL WEALTH MANAGEMENT, LTD. 61,225$3,780,0002.87%
Opus Point Partners Management, LLC 45,418$2,804,0002.77%
PINNACLE ASSOCIATES LTD 1,917,838$118,407,0002.32%
Ghost Tree Capital, LLC 50,000$3,087,0001.48%
Adamant Biomedical Investments AG 100,000$6,174,0001.48%
View complete list of ISIS PHARMACEUTICALS INC shareholders